0001104659-20-062414.txt : 20200515
0001104659-20-062414.hdr.sgml : 20200515
20200515135820
ACCESSION NUMBER: 0001104659-20-062414
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200515
FILED AS OF DATE: 20200515
DATE AS OF CHANGE: 20200515
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Andrade Robert
CENTRAL INDEX KEY: 0001468308
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32295
FILM NUMBER: 20883626
MAIL ADDRESS:
STREET 1: C/O ADHEREX TECHNOLOGIES INC.
STREET 2: 4620 CREEKSTONE DRIVE, SUITE 200
CITY: DURHAM
STATE: NC
ZIP: 27703
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FENNEC PHARMACEUTICALS INC.
CENTRAL INDEX KEY: 0001211583
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: A1
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: PO BOX 13628
STREET 2: 68 TW ALEXANDER DRIVE
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: (919) 636-4530
MAIL ADDRESS:
STREET 1: PO BOX 13628
STREET 2: 68 TW ALEXANDER DRIVE
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
FORMER COMPANY:
FORMER CONFORMED NAME: FENNEC PHARMACEUTICALS, INC.
DATE OF NAME CHANGE: 20140903
FORMER COMPANY:
FORMER CONFORMED NAME: ADHEREX TECHNOLOGIES INC
DATE OF NAME CHANGE: 20021223
4
1
tm2019938d3_4.xml
OWNERSHIP DOCUMENT
X0306
4
2020-05-15
0
0001211583
FENNEC PHARMACEUTICALS INC.
FENC
0001468308
Andrade Robert
68 TW ALEXANDER DRIVE, PO BOX 13628
DURHAM
NC
27709
0
1
0
0
Chief Financial Officer
Stock Option (right to buy)
6.93
2020-05-15
4
A
0
125000
0
A
2030-05-15
Common Shares
125000
125000
D
On May 15, 2020, Robert Andrade was granted an incentive stock option to purchase 125,000 shares of the Issuer's common shares pursuant to the Issuer's Amended and Restated Stock Option Plan.
1/3 of the shares subject to this option shall vest immediately and may be exercised as of May 15, 2021 (the "Vesting Commencement Date"). 1/24 of the shares subject to this option shall vest immediately and may be exercised as of the last day of each month following the Vesting Commencement Date. As of May 15, 2023 and thereafter, 100% of the total number of shares subject to this option shall be vested.
/s/ Robert Andrade
2020-05-15